Answers are grounded in this paper and cite their sources.
This roadmap assesses the replicability of PIISA project outcomes in various European contexts, indicating broad applicability.
The Replicability Roadmap is the final output of Task 4.5 under Work Package 4 (WP4) of the PIISA project. Its objective is to assess and structure how the results generated by the PIISA pilots can be replicated, transferred, or adapted to other European contexts beyond the original pilot locations, while remaining aligned with local regulatory, market, and institutional conditions. The roadmap builds on a comprehensive replicability assessment carried out across five WP3 pilots covering agriculture, forestry, wildfire risk, urban nature-based solutions, and household exposure to climate risks. Replicability is analysed through a harmonised framework encompassing four dimensions: technical feasibility, policy and regulatory fit, market readiness, and operational scalability. This assessment is informed by structured questionnaires completed by pilot leaders, technical and market deliverables produced under WP1 and WP3, and an update phase conducted in October–November 2025.
No takes yet. Share an insight, caveat, or question.
George Lameh (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: